Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-122 rollover study
NL-OMON58846Phase 1Completed
- Sponsor
- Celgene Corporation
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of avadomide, sponsored by Celgene Corporation. Started Feb 2023; status: completed.
02
Drugs
avadomide
Beyond the preview
Go deeper on NL-OMON58846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58846.